Updates on the Neurological Impact of COVID-19
Already an ASHA Learning Pass subscriber?
This session addresses the question of why patients with COVID-19 have such diverse clinical presentations. The speaker zooms in at the microscopic level to explore the nature and frequency of neurologic sequelae of COVID-19, covering findings observed on neuroimaging and cerebrospinal fluid testing. The session summarizes data from neuropathological studies, discusses new studies on the involvement of the peripheral nervous system, and explores treatment considerations.
This course is a recorded session from the "2022 ASHA Health Care Summit: Grand Rounds in COVID-19 Rehab" online conference.
You will be able to:
- Name common neurological symptoms and brain MRI and cerebrospinal fluid findings in people who were hospitalized with COVID-19
- Describe key features from neuropathological studies of COVID-19
- Discuss emerging neurological patterns observed in post-acute sequelae of COVID-19/post-COVID-19 condition
History and CE Information
origination date: June 2022
End date: August 18,
is offered for 0.05 ASHA CEUs (Intermediate level, Professional area).
To earn continuing
education credit, you must complete the learning assessment by August 18,